By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Proximagen Neuroscience plc 

Hodgkin Building - Guy's Campus
King's College London
London    SE1 1UL  United Kingdom
Phone: 44-0-207-848-6938 Fax: 44-0-207-848-6034


SEARCH JOBS


Industry
Pharmaceutical






Company News
Ligand Pharmaceuticals Inc. (LGND) Enters into Agreement with Proximagen Neuroscience plc (PRX.L) for CXCR4 Target 9/17/2010 7:03:56 AM
Proximagen Neuroscience plc (PRX.L) Signs Sale And Purchase Agreement For Sabcomeline 8/4/2010 11:38:47 AM
Proximagen Neuroscience plc (PRX.L) Release: Interim Results For The Six Months Ended 31 May 2010 7/28/2010 10:37:34 AM
Proximagen Neuroscience plc (PRX.L) Enters Into A Collaboration Agreement With The National Institutes of Health (NIH) For A Phase II Clinical Trial On Naluzotan 7/7/2010 10:16:26 AM
Proximagen Neuroscience plc (PRX.L) Sublicenses Tonabersat Drug Rights in North America to Upsher-Smith Laboratories 4/12/2010 6:54:36 AM
Proximagen Neuroscience plc (PRX.L): Unaudited Preliminary Results for the Year Ended 30 November 2009 3/30/2010 4:02:31 PM
Proximagen Neuroscience plc (PRX.L) Announces Positive Efficacy Results In National Institutes of Health (NIH) Epilepsy Studies 3/11/2010 12:06:26 PM
Proximagen Neuroscience plc (PRX.L) Recruits Senior GlaxoSmithKline (GSK) Executive As Non-Executive Director 2/1/2010 2:22:41 PM
Proximagen Neuroscience plc (PRX.L) Strategic Update 2/1/2010 1:08:26 PM
Proximagen Neuroscience plc (PRX.L) Signs to Acquire Cambridge Biotechnology from Biovitrum AB 10/22/2009 8:16:54 AM
12
//-->